title: Implications of Risk Evaluation and Mitigation Strategy (REMS) programs for managed care pharmacy.
abstract: In the last 2 decades, health care management has been challenged by more aggressive therapy, the increased number of specialty medications, and more stringent guidelines to monitor adverse events or health risk. To promote patient safety, various communication requirements are mandated to increase the risk awareness of patients and physicians. These include black-box warnings, "Dear Health Care Provider" letters, U.S. Food and Drug Administration (FDA) Talk Papers, MedGuides, and Risk Minimization Action Plans (RiskMAPs).
authors.forename: Gaurang
authors.initials: G
authors.lastname: Gandhi
authors.forename: Ashley
authors.initials: A
authors.lastname: Chon
authors.forename: Nik
authors.initials: N
authors.lastname: Johnson
authors.forename: Phyllis A
authors.initials: PA
authors.lastname: Kidder
authors.forename: Peter
authors.initials: P
authors.lastname: Lee
authors.forename: Kevin
authors.initials: K
authors.lastname: Leung
authors.forename: Ingrid
authors.initials: I
authors.lastname: Ma
authors.forename: Stacey
authors.initials: S
authors.lastname: Ness
authors.forename: Elizabeth
authors.initials: E
authors.lastname: Sampsel
authors.forename: Marissa
authors.initials: M
authors.lastname: Schlaifer
authors.forename: Randall
authors.initials: R
authors.lastname: Seifert
authors.forename: Debora B
authors.initials: DB
authors.lastname: Sternaman
mesh_terms: D064420:Drug-Related Side Effects and Adverse Reactions; D006801:Humans; D008329:Managed Care Programs / Q000592:standards*; D061214:Patient Safety / Q000331:legislation & jurisprudence / Q000592:standards; D010593:Pharmaceutical Services / Q000592:standards*; D012308:Risk Management / Q000379:methods / Q000592:standards*; D014481:United States; D014486:United States Food and Drug Administration / Q000331:legislation & jurisprudence / Q000592:standards